C Chapelle
Overview
Explore the profile of C Chapelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mano C, Chapelle C, Kabakian A, Gross P, Paradis H, Delaune O, et al.
Appl Radiat Isot
. 2023 Nov;
203:111079.
PMID: 37951035
In the scope of the verification regime of the Comprehensive nuclear Test Ban Treaty, the CEA/DAM is developing new β-γ measurement systems. In order to improve the analysis methods at...
2.
Douillet D, Chapelle C, Ollier E, Mismetti P, Roy P, Laporte S
PLoS Med
. 2022 Jul;
19(7):e1004059.
PMID: 35849624
Background: Lower limb trauma requiring immobilization is a significant contributor to overall venous thromboembolism (VTE) burden. The clinical effectiveness of thromboprophylaxis for this indication and the optimal agent strategy are...
3.
Catella J, Costes F, Gaultier J, Court Fortune I, Tulane C, de Magalhaes E, et al.
Respir Physiol Neurobiol
. 2020 May;
279:103467.
PMID: 32464180
The ratio of the diffusing capacity of the lung for carbon monoxide (DLCO) and for nitric oxide (DLNO) measured simultaneously is modified in patients with precapillary pulmonary hypertension (PH). The...
4.
Trone J, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, et al.
Ann Oncol
. 2018 Feb;
29(4):803-811.
PMID: 29415169
Background: Previous meta-analyses have shown paradoxical increased risk of bleeding and thrombotic events in patients receiving antiangiogenics (AA) that may be simply explained by the studies design included. By a...
5.
Laporte S, Chapelle C, Bertoletti L, Ollier E, Zufferey P, Lega J, et al.
J Thromb Haemost
. 2017 May;
15(8):1547-1558.
PMID: 28544422
Essentials Surrogacy of clinically relevant bleeding (CRB) for major bleeding has never been validated. Our meta-analysis evaluated CRB surrogacy in trials of new versus traditional anticoagulants. Surrogacy was not validated...
6.
Tardy B, Picard S, Guirimand F, Chapelle C, Danel Delerue M, Celarier T, et al.
J Thromb Haemost
. 2016 Dec;
15(3):420-428.
PMID: 28035750
Summary: Background The value of primary thromboprophylaxis in patients admitted to palliative care units is debatable. Moreover, the risk of bleeding in these patients is unknown. Objectives Our primary aim...
7.
Chalayer E, Chapelle C, Leleu X, Elalamy I, Laporte S, Tardy B
Thromb Res
. 2016 May;
143:101-2.
PMID: 27208979
No abstract available.
8.
Boilot T, Raia-Barjat T, Ollier E, Chapelle C, Laporte S, Chauleur C
Gynecol Obstet Fertil
. 2015 Jul;
43(7-8):502-8.
PMID: 26190567
Objectives: The objective of the study was to evaluate the influence of anticoagulation on intrapartum anesthesia and delivery modalities. Methods: This ancillary study is concerned with anticoagulated patients included in...
9.
Tardy B, Chalayer E, Chapelle C, Mismetti P
J Thromb Haemost
. 2014 Jul;
12(9):1572-3.
PMID: 24976020
No abstract available.
10.
Laporte S, Chapelle C, Bertoletti L, Lega J, Cucherat M, Zufferey P, et al.
Thromb Haemost
. 2014 Jun;
112(3):503-10.
PMID: 24965841
Two enoxaparin dosage regimens are used as comparators to evaluate new anticoagulants for thromboprophylaxis in patients undergoing major orthopaedic surgery, but so far no satisfactory direct comparison between them has...